• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

1997 Fiscal Year Final Research Report Summary

Assessment of vascularity andviability of the liver and liver tumors using the liver specific contrast agent in MR imaging

Research Project

Project/Area Number 08671014
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Radiation science
Research InstitutionFukui Medical University

Principal Investigator

KAWAMURA Yasutaka  Fukui Medical University, Medical Hospital, Lecturer, 医学部附属病院, 講師 (30214703)

Project Period (FY) 1996 – 1997
KeywordsMRI / Liver, Neoplasm / Liver, Reticuloendothelial System / Contrast Media / Perfusion / 血流
Research Abstract

PURPOSE : Although SPIO-enhanced MRI is excellent for detecting small liver tumors, its lack of tumor vascularity makes it difficult in evaluating tumor viability of follow-up cases. We applied dynamic SPIO-MRI to obtain perfusion data of the liver and liver tumors.
MATERIALS AND METHODS : Seven patients with hepatocellular carcinoma, five with liver metastases and two with cholangiocarcinoma were enrolled in this study. SPIO-MRI was performed with a 1.5 Tesla unit (Signa Horizon, GE : WI), dynamic contrast-enhanced CT (High Speed Advantage, GE : WI) and liver angiography were performed on all patients. The dynamic SPIO-MRI was performed in eight cases.
The SPIO (Nihon Schering, Japan) has a size of 4.2 nm (core) and 55 nm (whole particle) Its T1-and T2-relaxitivities are 9.48 and 229.5 mM-1・sec-1 on our GE 1.5-T Signa. T2-weighted images (Fast SE : TR/TE=4100/80-90), breath-holding gradient echo images (TR/TE=100/2.7 ; Flip Angle=20゚) were obtained before and after the dynamic SPIO-MRI. … More The T1-weighted dynamic MRI were performed with the bolus injection of 8 mmol Fe/kg of SPIO (FMP SPGR : TR/TE=110/2.7-4.1 ; Flip Angle=90゚ ; 12 seconds/11 slices).
The number and the delineation of tumors and the pattern of enhancement (homogeneous or inhomogeneous) were assessed on each images with no knowledge of patient history and image sequences. Results obtained from angiography were used as the gold standard for the tumor number.
RESULTS : Out of 32 nodules confirmed by the angiography, 24 (75%) and 17 (53%) were detected on SPIO-MRI and dynamic-CT,respectively. However, seven false-positive lesions were noticed on SPIO-MRI,possibly due to regeneration nodules associating liver cirrhosis.
Five hepatocellular carcinoma patients and two metastases patients had been treated by trans arterial chemoembolization therapy more than one month prior to this study. In those cases, CT clearly demonstrated central high density due to effective lipiodol accumulation within the nodules and peripheral enhancement indicating viable tumor. However, SPIO-MRI showed tumors as homogeneous hyperintensity nodules in which tumor viability could not be assessed.
Dynamic SPIO-MRI revealed tumor perfusion in 14 major lesions otherwise tumor necrosis and viable portion could not be differentiated on SPIO-MRI.
DISCUSSION : The use of SPIO could improve the detectability of small liver tumors on MRI,however, false-positive results and its insensitivity of tumor vascularity might cause problem in screening liver disease. To apply the dynamic SPIO-MRI could supply perfusion data of the liver and liver tumors and helped diagnostic quality. Less

  • Research Products

    (6 results)

All Other

All Publications (6 results)

  • [Publications] 河村 泰孝: "diffusion/perfusion MRIについて" 臨床画像. 13・7. 108-121 (1997)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 河村 泰孝: "MRI造影剤の特性" medicina. 34・11. 31-41 (1997)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Yasutaka Kawamura: "Dynamic MRI with Superparamagnetic Iron Oxide Particles in Evaluating Vascularity and Viability of Liver Tumors" Investigative Radiology. (掲載予定). (1998)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Y.Kawamura: "Clinical Utility of Diffusion/Perfusion MRI" Clinical Imagiology. 13 (7). 108-121 (1997)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Y.Kawamura: "Characteristics of MRI Contrast Agents" medicina. 34 (11). 31-41 (1997)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Y.Kawamura: "Assessment of Vascularity and Viability of the Liver and Liver Tumors using the Liver Specific Contrast Agent in MR Imaging" Investigative Radiology. (in press). (1998)

    • Description
      「研究成果報告書概要(欧文)」より

URL: 

Published: 1999-03-16  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi